Young James Emmett has filed 6 insider transactions across 1 company since January 2025.
Most recent transaction: a grant/award of 13175 shares of TriSalus Life Sciences, Inc. ($TLSI) on May 19, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Young James Emmett | Chief Financial Officer | A | Common Stock | 13175 | $5.18 | 79,663.0000 | 32,272,462 | 19.82% | 0.04% |
| Feb. 18, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Young James Emmett | Chief Financial Officer | A | Common Stock | 14762 | $0.00 | 66,488.0000 | 0 | 28.54% | 0.00% |
| Feb. 5, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Young James Emmett | Chief Financial Officer | P | Common Stock | 6000 | $5.65 | 51,726.0000 | 0 | 13.12% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Young James Emmett | Chief Financial Officer | A | Common Stock | 12500 | $0.00 | 45,726.0000 | 0 | 37.62% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Young James Emmett | Chief Financial Officer | P | Common Stock | 24000 | $5.40 | 45,726.0000 | 0 | 110.47% | 0.00% |
| Jan. 27, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Young James Emmett | Chief Financial Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |